Assessment shows improved overall survival and disease-free survival in anal canal carcinoma patients, indicating effective treatment.
Anal canal carcinoma is an uncommon malignancy and concurrent chemoradiation is the standard of care curative treatment in locally advanced anal canal carcinoma. Concurrent chemoradiation have resulted in good outcomes in terms of overall survival, disease free survival. With this study we wanted to assess the clinical outcome of patients with Anal canal carcinoma treated with radical chemoradiation at our centre.
No takes yet. Share an insight, caveat, or question.
Suresh et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: